1-5 of 5
Salvatore Perrone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Treatment of Hairy Cell Leukemia Patients with Interferon: Clinical and Molecular Aspects

Giovanni Manfredi Assanto, MD, Costantino Riemma, MD, Francesco Malaspina, MD, Salvatore Perrone, MD, Maria Lucia De Luca, MD, Giorgia Annechini, MD, Gianna Maria D'elia, Maurizio Martelli, MD, Robin Foà, MD, Enrico Tiacci, Alessandro Pulsoni, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
DOI: https://doi.org/10.1182/blood-2020-136660
Published: 2020
Journal Articles

Acute Promyelocytic Leukemia (APL) in Very Elderly Patients: Real-Life behind Protocols

Serena Rosati, MD, Massimo Breccia, MD, Carmelo Gurnari, MD, Ida Carmosino, Emilia Scalzulli, MD, Enrico Montefusco, Salvatore Perrone, MD, Ombretta Annibali, Vincenza Martini, MD, Giulio Trapè, Malgorzata Monika Trawinska, MD, Clara Minotti, MD, Giuseppe Cimino, MD, Agostino Tafuri, MD, Giuseppe Avvisati, MD, Maria Teresa Voso, MD, Robin Foà, MD, Roberto Latagliata
Journal: Blood
Blood (2019) 134 (Supplement_1): 3845.
DOI: https://doi.org/10.1182/blood-2019-129216
Published: 2019
Journal Articles

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marco Foppoli, Stefania Girlanda, Marianna Sassone, Salvatore Perrone, Caterina Cecchetti, Fabio Ciceri, Claudio Bordignon, Angelo Corti, Nicoletta Anzalone
Journal: Blood
Blood (2019) 134 (3): 252–262.
DOI: https://doi.org/10.1182/blood.2019000633
Published: 2019
Includes: Supplemental data
Journal Articles

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Andres JM Ferreri, MD, Teresa Calimeri, MDPhD, Gian Marco Conte, MD, Dario Cattaneo, MD, Federico Fallanca, MD, Maurilio Ponzoni, MD, Eloise Scarano, Marianna Sassone, MD, Salvatore Perrone, MD, Caterina Cecchetti, MD, Paolo Lopedote, MD, Fiorella Ilariucci, Roberta Rudà, MD, Emanuele Angelucci, MD, Carlo Visco, Francesco Pisani, MD, Alberto Fabbri, MD, Luigi Petrucci, MD, Marco Bregni, MD, Dario Marino, MDPhD, Guido Gini, MD, Fabio Ciceri, MD, Angelo Corti, MD, Nicoletta Anzalone, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1687.
DOI: https://doi.org/10.1182/blood-2018-99-118507
Published: 2018
Journal Articles

Multicenter Phase II Trial Addressing Lenalidomide Maintenance in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Efficacy and Safety Results after a Median Follow-up of Five Years

Andres JM Ferreri, MD, Marianna Sassone, MD, Francesco Zaja, MD, Alessandro Re, MD, Michele Spina, MD, Alice Di Rocco, Alberto Fabbri, MD, Piera Angelillo, MD, Caterina Stelitano, MD, Maurizio Frezzato, MD, Chiara Rusconi, Renato Zambello, MD, Annalisa Arcari, MD, Giovanni Bertoldero, MD, Daniela De Lorenzo, BD, Eloise Scarano, Stefano Volpetti, MD, Salvatore Perrone, MD, Teresa Calimeri, MDPhD, Caterina Cecchetti, MD, Fabio Ciceri, MD, Maurilio Ponzoni, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1688.
DOI: https://doi.org/10.1182/blood-2018-99-116060
Published: 2018